- Home
- AVTX vs APOG Comparison
AVTX vs APOG Comparison
Compare AVTX & APOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVTX | APOG |
|---|---|---|
| Founded | 2011 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 710.1M | 794.2M |
| IPO Year | 2015 | 1994 |
Fundamental Metrics
Financial Performance| Metric | AVTX | APOG |
|---|---|---|
| Price | $7.81 | $47.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 14 | 0 |
| Target Price | $34.80 | ★ $45.50 |
| AVG Volume (30 Days) | ★ 2.9M | 234.5K |
| Earning Date | 11-05-2026 | 10-06-2026 |
| Dividend Yield | N/A | ★ 2.28% |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ 1.61 |
| Revenue | $27,813,137.00 | ★ $1,404,733,000.00 |
| Revenue This Year | N/A | $5.63 |
| Revenue Next Year | N/A | $6.57 |
| P/E Ratio | ★ N/A | $29.45 |
| Revenue Growth | ★ 2312.27 | 3.21 |
| 52 Week Low | $6.53 | $30.75 |
| 52 Week High | $24.27 | $50.88 |
Technical Indicators
Market Signals| Indicator | AVTX | APOG |
|---|---|---|
| Relative Strength Index (RSI) | 38.51 | 61.07 |
| Support Level | $6.53 | $37.05 |
| Resistance Level | $20.54 | $50.88 |
| Average True Range (ATR) | 0.62 | 1.60 |
| MACD | 0.36 | -0.04 |
| Stochastic Oscillator | 62.35 | 57.11 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About APOG Apogee Enterprises Inc.
Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company geographically operates in the United States, Canada, and Brazil, with the majority revenue generated from the United States.